Judge rejects Purdue Pharma's opioid settlement that would protect Sackler family

By Steve Inskeep,

Brian Mann

Published December 17, 2021 at 6:26 AM EST

Purdue Pharma, maker of the highly addictive OxyContin, is keeping secret the results of an investigation of the Sacklers. Critics want the findings made public. — A federal judge on Thursday, rejected OxyContin maker Purdue Pharma's bankruptcy settlement of thousands of lawsuits over the opioid epidemic because of a provision that would protect members of the Sackler family from lawsuits.

A federal judge has overturned the $4.5 billion settlement between Purdue Pharma, which makes OxyContin, and the Sackler family, that would have protected the family from litigation of their own.

Related Content

Local News

AG Donovan says he's committed to challenging bankruptcy plan for opioid drugmaker

Liam Elder-Connors

Last week, the state of Vermont and four others filed a legal brief seeking to reverse a bankruptcy plan for Purdue Pharma. Vermont Attorney General TJ Donovan says it doesn't hold the company's owners sufficiently accountable.
NPR News

To save lives, overdose antidote should be sold over-the-counter, advocates argue

Aneri Pattani

With opioid overdoses surging, harm-reduction groups are calling on the FDA to change naloxone's prescription-only status. This would make it easier to get the lifesaving drug to people at risk.
NPR News

Drug overdose deaths in the U.S. have topped 100,000 for the first time

Brian Mann

The Biden administration scrambles to respond as new data from the Centers for Disease Control and Prevention show overdose deaths surged to more than 100,000 fatalities.